Colgate‑Palmolive: Market‑Strong Consumer Staples Powerhouse Near Earnings Call
Colgate‑Palmolive: Explore its diverse consumer‑staple product line, stable 2025 earnings outlook, and premium stock valuation for investors.
3 minutes to read
Colgate-Palmolive Co
Colgate‑Palmolive Q3 2025: 2% Revenue Growth, EPS Beats Forecast, Slashed Sales Guidance
Colgate‑Palmolive’s Q3 2025 earnings show steady 2% revenue growth and EPS beating estimates, but a trimmed sales outlook amid consumer restraint.
2 minutes to read
Colgate-Palmolive Reports Mixed Q1 2025 Results with Organic Sales Growth Amidst Net Sales Decline
Colgate-Palmolive reported a 3.1% decline in net sales for Q1 2025, but saw increases in organic sales and earnings, with GAAP EPS rising 2% to $0.85.
2 minutes to read